Loading...

Many Bright Ideas Technologies Inc.

MBGNFPNK
Healthcare
Medical - Diagnostics & Research
$0.01
$0.00(0.00%)

Many Bright Ideas Technologies Inc. (MBGNF) Financial Performance & Income Statement Overview

Explore the financials of Many Bright Ideas Technologies Inc. (MBGNF), including yearly and quarterly data on income, cash flow, and balance sheets.

Revenue Growth
0.00%
Operating Income Growth
11.35%
11.35%
Net Income Growth
11.35%
11.35%
Operating Cash Flow Growth
0.00%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
35.36%
35.36%
ROIC
32.27%
32.27%

Many Bright Ideas Technologies Inc. (MBGNF) Income Statement & Financial Overview

Review Many Bright Ideas Technologies Inc. MBGNF income statement with detailed quarterly and annual figures.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$0.00$0.00$0.00$0.00
Cost of Revenue$0.00$0.00$0.00$0.00
Gross Profit$0.00$0.00$0.00$0.00
Gross Profit Ratio$0.00$0.00$0.00$0.00
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$12808.00$10804.00$19998.00$10086.00
Operating Expenses$12808.00$10804.00$19998.00$10132.00
Total Costs & Expenses-$12808.00$10804.00$19998.00$10132.00
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$0.00$0.00$0.00$8384.00
EBITDA-$12808.00-$10804.00-$19998.00-$1748.00
EBITDA Ratio
Operating Income-$12808.00$0.00-$19998.00-$10132.00
Operating Income Ratio
Other Income/Expenses (Net)$0.00$0.00$0.00$0.00
Income Before Tax-$12808.00-$10804.00-$19998.00-$10132.00
Income Before Tax Ratio
Income Tax Expense$0.00$0.00$0.00$0.00
Net Income-$12808.00-$10804.00-$19998.00-$10132.00
Net Income Ratio
EPS-$0.001-$0.001-$0.001-$0.001
Diluted EPS-$0.001-$0.001-$0.001-$0.001
Weighted Avg Shares Outstanding$17.26M$17.26M$17.26M$17.26M
Weighted Avg Shares Outstanding (Diluted)$17.26M$17.26M$17.26M$17.26M

Financial performance has remained strong, with revenue growing from $0.00 in Q1 2024 to $0.00 in Q4 2024. Gross profit continued to perform well, with margins at N/A in the latest quarter. Operating income reached -$12808.00 in Q4 2024, holding a steady N/A margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$12808.00. Net income dropped to -$12808.00, keeping EPS at -$0.001. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;